Infertility, Female

The supplied literature supports several associated causes or contributors, including polycystic ovary syndrome, endometriosis, and ovarian damage from chemotherapy or radiotherapy. Oxidative stress is also described as a contributor to subfertility and unexplained infertility, although its impact on female reproductive tissues is noted as less clear than in males.

The grounding highlights ovarian reserve and ovulation as key mechanisms relevant to female infertility. It also supports oxidative stress as a biological process that can disrupt reproductive function, and in chemotherapy-related infertility, follicle loss and ovarian injury are central mechanisms.

Higher body mass index and obesity are associated with poorer fertility prognosis, and extremes of body weight are linked with reproductive dysfunction. Lifestyle factors such as cigarette smoking and alcohol use are also mentioned in relation to oxidative stress and reproductive disease. Exposure to anti-cancer therapy, including chemotherapy and radiotherapy, increases risk of ovarian damage and infertility.

Management is described at the level of therapy and drug therapy rather than specific regimens. The grounding supports treatment approaches for PCOS, fertility-protective strategies during chemotherapy, and cryopreservation of oocytes, embryos, or ovarian cortex for some women with cancer-induced infertility. It also mentions GLP-1 receptor agonists as an emerging therapeutic option in obese women with PCOS.